Valuation : Genpharmasec Limited

Market Cap 432M 4.57M 3.94M 3.7M 3.38M 6.33M 6.35M 43.76M 16.98M 222M 17.18M 16.8M 714M P/E 2024
-545x
P/E 2025 94.5x
Enterprise Value 422M 4.47M 3.85M 3.62M 3.31M 6.19M 6.21M 42.81M 16.61M 217M 16.8M 16.44M 698M EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
54.91%
Yield 2024 *
-
Yield 2025 -
1 day+0.81%
1 week+21.36%
Current month+10.62%
1 month+19.05%
3 months+10.62%
6 months+8.70%
Current year-4.58%
1 week 1.02
Extreme 1.02
1.36
1 month 0.9
Extreme 0.9
1.36
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.15
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
11.08
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 39 2022-10-31
Compliance Officer - 2024-03-26
Director TitleAgeSince
Director/Board Member 57 2019-01-01
Director/Board Member 58 2019-01-01
Director/Board Member - 2022-10-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%+21.36%-34.90%-69.66% 7.33M
-0.42%-3.68%-18.51%+7.39% 187B
+1.15%+3.22%+1.37%+17.42% 120B
-1.86%+2.77%+13.15%+91.44% 63.15B
-1.31%-1.09%+17.67%+43.65% 51.75B
-1.54%-2.52%-3.98%-32.30% 50.32B
-2.02%-3.22%+9.18%-12.39% 33.17B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+35.59%-15.78% 23.93B
-1.44%-4.21%-8.07%+11.30% 22.99B
Average -0.74%+2.07%+1.28%+4.56% 58.53B
Weighted average by Cap. -0.55%+0.02%-1.43%+16.92%

Financials

2024 2025
Net sales 304M 3.22M 2.77M 2.61M 2.38M 4.46M 4.47M 30.81M 11.96M 156M 12.09M 11.83M 503M 337M 3.57M 3.07M 2.89M 2.64M 4.94M 4.95M 34.17M 13.26M 173M 13.41M 13.12M 557M
Net income -1.26M -13.31K -11.46K -10.78K -9.85K -18.42K -18.47K -127K -49.42K -645K -49.99K -48.9K -2.08M 12.31M 130K 112K 106K 96.44K 180K 181K 1.25M 484K 6.32M 490K 479K 20.35M
Net Debt -179M -1.89M -1.63M -1.53M -1.4M -2.62M -2.63M -18.12M -7.03M -91.77M -7.11M -6.96M -296M -9.4M -99.59K -85.7K -80.63K -73.66K -138K -138K -953K -370K -4.82M -374K -366K -15.54M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
26-09-04 ₹1.250 +0.81% 1,191,433
26-09-03 ₹1.240 0.00% 1,445,916
26-09-02 ₹1.240 +5.08% 3,448,139
26-09-01 ₹1.180 +4.42% 4,171,929
26-08-31 ₹1.130 +9.71% 5,730,632
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock